These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2566649)

  • 21. Abnormal expression of serotonin transporter mRNA in the frontal and temporal cortex of schizophrenics.
    Hernandez I; Sokolov BP
    Mol Psychiatry; 1997 Jan; 2(1):57-64. PubMed ID: 9154218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia.
    Zavitsanou K; Ward PB; Huang XF
    Neuropsychopharmacology; 2002 Nov; 27(5):826-33. PubMed ID: 12431856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.
    Joyce JN; Shane A; Lexow N; Winokur A; Casanova MF; Kleinman JE
    Neuropsychopharmacology; 1993 Jun; 8(4):315-36. PubMed ID: 8512620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS.
    Sardar AM; Hutson PH; Reynolds GP
    Neuroreport; 1999 Nov; 10(17):3513-5. PubMed ID: 10619635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperinnervation of orbital frontal cortex in schizophrenia.
    Deakin JF; Slater P; Simpson MD; Royston MC
    Br J Psychiatry; 1990 Sep; 157():459-60. PubMed ID: 1978787
    [No Abstract]   [Full Text] [Related]  

  • 26. The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia.
    Moore H; West AR; Grace AA
    Biol Psychiatry; 1999 Jul; 46(1):40-55. PubMed ID: 10394473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebral glutamate, neuroleptic drugs and schizophrenia: increase of cerebrospinal fluid glutamate levels and decrease of striate body glutamate levels following sulpiride treatment in rats.
    Kim JS; Claus D; Kornhuber HH
    Eur Neurol; 1983; 22(5):367-70. PubMed ID: 6138256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A; Galińska B; Tarasów E; Walecki J; Dzienis W; Kubas B; Czernikiewicz A
    Psychiatr Pol; 2003; 37(6):977-88. PubMed ID: 14727370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia.
    Yang CQ; Kitamura N; Nishino N; Shirakawa O; Nakai H
    Biol Psychiatry; 1998 Jan; 43(1):12-9. PubMed ID: 9442339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-aspartate binding to the glutamate uptake site in human brain tissue--effects of leucotomy.
    Cutts AJ; Reynolds GP
    J Neural Transm Gen Sect; 1993; 94(2):147-52. PubMed ID: 8110441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies in postmortem dopamine uptake. II. Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia.
    Haberland N; Hetey L
    J Neural Transm; 1987; 68(3-4):303-13. PubMed ID: 3559542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.
    Procter AW; Wong EH; Stratmann GC; Lowe SL; Bowen DM
    J Neurochem; 1989 Sep; 53(3):698-704. PubMed ID: 2569500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactive memory systems and category learning in schizophrenia.
    Kéri S
    Neurosci Biobehav Rev; 2008; 32(2):206-18. PubMed ID: 17854895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional distribution of pre- and postsynaptic glutamatergic function in Alzheimer's disease.
    Cowburn R; Hardy J; Roberts P; Briggs R
    Brain Res; 1988 Jun; 452(1-2):403-7. PubMed ID: 2900052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.
    Buckley PF; Moore C; Long H; Larkin C; Thompson P; Mulvany F; Redmond O; Stack JP; Ennis JT; Waddington JL
    Biol Psychiatry; 1994 Dec; 36(12):792-800. PubMed ID: 7893844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophrenia.
    Nudmamud S; Reynolds GP
    Neurosci Lett; 2001 May; 304(1-2):9-12. PubMed ID: 11335042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients.
    Siegel BV; Buchsbaum MS; Bunney WE; Gottschalk LA; Haier RJ; Lohr JB; Lottenberg S; Najafi A; Nuechterlein KH; Potkin SG
    Am J Psychiatry; 1993 Sep; 150(9):1325-36. PubMed ID: 8352343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontolimbic glutamate alterations in first episode schizophrenia: evidence from a magnetic resonance spectroscopy study.
    Olbrich HM; Valerius G; Rüsch N; Buchert M; Thiel T; Hennig J; Ebert D; Van Elst LT
    World J Biol Psychiatry; 2008; 9(1):59-63. PubMed ID: 17853298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of D-[3H]aspartic acid from the rat striatum. Effect of veratridine-evoked depolarization, fronto-parietal cortex ablation, and striatal lesions with kainic acid.
    Arqueros L; Abarca J; Bustos G
    Biochem Pharmacol; 1985 Apr; 34(8):1217-24. PubMed ID: 2581579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postnatal changes in N-methyl-D-aspartate receptor binding and stimulation by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex.
    Slater P; McConnell SE; D'Souza SW; Barson AJ
    Br J Pharmacol; 1993 Apr; 108(4):1143-9. PubMed ID: 8097954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.